EcoDrugPlus

Spleen Tyrosine Kinase

Ensembl ID : ENSOMEG00000000163
Gene Symbol: SYK
1 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSOMEG00000008887
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSOMEG00000010946
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOMEG00000022543
Gene Symbol: TACR1
4 Cross references
194 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSOMEG00000022591
Gene Symbol: TACR1B
1 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOMEG00000004871
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSOMEG00000008412
Gene Symbol: TACR3
4 Cross references
208 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSOMEG00000007265
Gene Symbol: TACR3L
1 Cross references
218 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSOMEG00000006967
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Telomerase Reverse Transcriptase-Like

Ensembl ID : ENSOMEG00000012908
Gene Symbol: LOC112136283
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSOMEG00000022710
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSOMEG00000019865
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).